O08 Blindness in patients with giant cell arteritis and its association with vascular disease

O08 Blindness in patients with giant cell arteritis and its association with vascular disease

Bibliographic Details
Main Authors:	Yates, M, Macgregor, A, Robson, J, Craven, A, Merkel, P, Luqmani, R, Watts, R
Format:	Conference item
Published:	Oxford University Press 2016

Similar Items

The association of vascular risk factors with visual loss in giant cell arteritis
by: Yates, M, et al.
Published: (2016)

The frequency and severity of patient-reported symptoms in giant cell arteritis
by: Monti, S, et al.
Published: (2017)

THE FREQUENCY AND SEVERITY OF PATIENT-REPORTED SYMPTOMS IN GIANT CELL ARTERITIS
by: Monti, S, et al.
Published: (2017)

FRI0312 The frequency and severity of patient-reported symptoms in giant cell arteritis
by: Monti, S, et al.
Published: (2017)

SY4_1 Giant cell arteritis (GCA) and Takayasu arteritis (TAK): a spectrum within the same disease or not? A report from the DCVAS project
by: Luqmani, R, et al.
Published: (2017)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
by: Ponte, C, et al.
Published: (2022)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
by: Ponte, C, et al.
Published: (2022)

Vascular Endothelial Growth Factor as an Aid to Diagnosis of Giant Cell Arteritis
by: Goodfellow, N, et al.
Published: (2016)

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?
by: Goodfellow, N, et al.
Published: (2017)

Giant cell arteritis: Current treatment and management
by: Ponte, C, et al.
Published: (2015)

FRI0028 Vascular Endothelial Growth Factor as An Aid To Diagnosis of Giant Cell Arteritis
by: Goodfellow, N, et al.
Published: (2016)

PREDICTORS OF AORTIC ANEURYSMS FOR GIANT CELL ARTERITIS SUBJECTS
by: Robson, J, et al.
Published: (2013)

ROS producing immature neutrophils in Giant Cell Arteritis are linked to vascular pathologies
by: Wang, L, et al.
Published: (2020)

The United Kingdom and Ireland Vasculitis Registry: Cross-sectional data on the first 3195 patients with a focus on anti-neutrophil cytoplasm – associated vasculitis and giant cell arteritis
by: Luqmani, R, et al.
Published: (2017)

Treatment of polymyalgia rheumatica and giant cell arteritis: are we any further forward?
by: Luqmani, R
Published: (2007)

Tumor necrosis factor-blocking agents in polymyalgia rheumatica and giant cell arteritis - Reply
by: Luqmani, R
Published: (2008)

ROS-producing immature neutrophils in giant cell arteritis are linked to vascular pathologies
by: Lihui Wang, et al.
Published: (2020-10-01)

ARE WE MEETING THE STANDARDS FOR TEMPORAL ARTERY BIOPSY IN GIANT CELL ARTERITIS?
by: Soni, A, et al.
Published: (2009)

Giant Cell Arteritis
by: E. V. Shevchenko, et al.
Published: (2025-01-01)

European Headache Federation recommendations for neurologists managing giant cell arteritis
by: S. P. Mollan, et al.
Published: (2020-03-01)

The role of ultrasound in the management of giant cell arteritis in routine clinical practice
by: Monti, S, et al.
Published: (2017)

Updates on the diagnosis and monitoring of giant cell arteritis
by: Sara Monti, et al.
Published: (2023-02-01)

Giant cell arteritis: new concepts, treatments and the unmet need that remains
by: Coath, F, et al.
Published: (2018)

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK
by: Robson, J, et al.
Published: (2013)

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK.
by: Robson, J, et al.
Published: (2015)

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK
by: Robson, J, et al.
Published: (2015)

The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice
by: Monti, S, et al.
Published: (2017)

THU0297 A novel ultrasound scoring system for giant cell arteritis
by: Monti, S, et al.
Published: (2017)

THU0302 Histology findings in giant cell arteritis (GCA) and their relationship with the ultrasound results: analysis of data from the tabul study (temporal artery biopsy vs ultrasound in diagnosis of giant cell arteritis)
by: Ponte, C, et al.
Published: (2017)

Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study
by: Robson, J, et al.
Published: (2016)

2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis
by: Grayson, PC, et al.
Published: (2022)

2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis
by: Grayson, P, et al.
Published: (2022)

Giant cell arteritis: Its ophthalmic manifestations
by: Sohan Singh Hayreh
Published: (2021-01-01)

Methotrexate (MTX) failed to control giant cell arteritis (GCA)
by: Hoffman, G, et al.
Published: (2001)

P1_41 Histology findings in giant cell arteritis (GCA) and their relationship with the ultrasound results: analysis of data from the TABUL study (Temporal Artery Biopsy vs Ultrasound in diagnosis of Giant Cell Arteritis)
by: Ponte, C, et al.
Published: (2017)

Vascular-adhesion protein 1 in giant cell arteritis and polymyalgia rheumatica
by: Simon M. Petzinna, et al.
Published: (2024-08-01)

Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological Disorders
by: Ryu Watanabe, et al.
Published: (2022-04-01)

Giant cell arteritis
by: Dijana Perković, et al.
Published: (2021-04-01)

Giant Cell Arteritis
by: Bruno Coulier, et al.
Published: (2018-01-01)

Biologic Therapies for Giant Cell Arteritis
by: Harrington R, et al.
Published: (2021-01-01)